International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

S Kumar, B Paiva, KC Anderson, B Durie… - The lancet …, 2016 - thelancet.com
Treatment of multiple myeloma has substantially changed over the past decade with the
introduction of several classes of new effective drugs that have greatly improved the rates …

Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International …

M Cavo, E Terpos, C Nanni, P Moreau… - The lancet …, 2017 - thelancet.com
Summary The International Myeloma Working Group consensus aimed to provide
recommendations for the optimal use of 18 fluorodeoxyglucose (18 F-FDG) PET/CT in …

European Myeloma Network guidelines for the management of multiple myeloma-related complications

E Terpos, M Kleber, M Engelhardt… - …, 2015 - pmc.ncbi.nlm.nih.gov
The European Myeloma Network provides recommendations for the management of the
most common complications of multiple myeloma. Whole body low-dose computed …

PET/MRI: where might it replace PET/CT?

EC Ehman, GB Johnson… - Journal of Magnetic …, 2017 - Wiley Online Library
Simultaneous positron emission tomography and MRI (PET/MRI) is a technology that
combines the anatomic and quantitative strengths of MR imaging with physiologic …

Role of magnetic resonance imaging in the management of patients with multiple myeloma: a consensus statement

MA Dimopoulos, J Hillengass, S Usmani… - Journal of Clinical …, 2015 - ascopubs.org
Purpose The aim of International Myeloma Working Group was to develop practical
recommendations for the use of magnetic resonance imaging (MRI) in multiple myeloma …

Whole-body imaging of multiple myeloma: diagnostic criteria

AG Ormond Filho, BC Carneiro, D Pastore, IP Silva… - Radiographics, 2019 - pubs.rsna.org
Multiple myeloma (MM) is a clonal plasma cell proliferative disorder characterized by
primary infiltration of bone marrow and excessive production of abnormal immunoglobulin …

Interpretation criteria for FDG PET/CT in multiple myeloma (IMPeTUs): final results. IMPeTUs (Italian myeloma criteria for PET USe)

C Nanni, A Versari, S Chauvie, E Bertone… - European journal of …, 2018 - Springer
Materials and methods Patients affected by symptomatic MM who had performed an FDG
PET/CT at baseline (PET0), after induction (PET-AI), and the end of treatment (PET-EoT) …

Image interpretation criteria for FDG PET/CT in multiple myeloma: a new proposal from an Italian expert panel. IMPeTUs (Italian Myeloma criteria for PET USe)

C Nanni, E Zamagni, A Versari, S Chauvie… - European journal of …, 2016 - Springer
Abstract Purpose FDG PET/CT is able to detect active disease in patients with multiple
myeloma (MM) and can be helpful for staging and assessing therapy response, but no …

clinical PET/MRI: 2018 update

SM Broski, AH Goenka, BJ Kemp… - American Journal of …, 2018 - ajronline.org
OBJECTIVE. The purpose of this article is to provide an update on clinical PET/MRI,
including current and develo** clinical indications and technical developments …

Imaging of treatment response and minimal residual disease in multiple myeloma: state of the art WB-MRI and PET/CT

FE Lecouvet, MC Vekemans, T Van Den Berghe… - Skeletal radiology, 2022 - Springer
Bone imaging has been intimately associated with the diagnosis and staging of multiple
myeloma (MM) for more than 5 decades, as the presence of bone lesions indicates …